arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Tonix Pharmaceuticals Holding Corp.

TNXP

$11.99 ▲ +0.34 (+2.92%) at close

20 Visible periods

25 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Tonix Pharmaceuticals Holding Corp. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $102.1M

Dividend Yield —

Revenue Growth 29.8% →

Op. Margin —

ROIC -40.5% ↗

FCF / Share $-12.13 ↗

Trailing P/E —

Price / Book 0.6x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

20-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$13.11M

↑ +29.8% —

Net Income Profit after all expenses

$-124.02M

↑ +4.6% —

FCF / Share Free cash flow per share

$-12.13

↑ +85.4% —

Long-Term Debt Long-term obligations

$8.65M

↓ -21.4% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Jun 7, 2007 10-K ↗
Revenue Growth YoY (%)	29.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+273%)	29.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+274%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	91.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	98.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-73464.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-147.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	4.6% Caution ↑ Caution Improving Year-over-year change in net income	-11.5% Weak ↑ Weak Improving Year-over-year change in net income	-5.8% Weak ↑ Weak Improving Year-over-year change in net income	-19.4% Weak ↑ Weak Improving Year-over-year change in net income	-82.9% Weak ↓ Weak Declining Year-over-year change in net income	-76.3% Weak ↓ Weak Declining Year-over-year change in net income	-9.7% Weak ↓ Weak Declining Year-over-year change in net income	-23.5% Weak ↓ Weak Declining Year-over-year change in net income	45.6% Excellent ↑ Excellent Improving Year-over-year change in net income	19.2% Good ↑ Good Improving Year-over-year change in net income	-74.0% Weak ↑ Weak Improving Year-over-year change in net income	-153.7% Weak ↓ Weak Declining Year-over-year change in net income	31.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-356.6% Weak ↓ Weak Declining Year-over-year change in net income	-76.6% Weak ↑ Weak Improving Year-over-year change in net income	-788.9% Weak Weak Year-over-year change in net income	-9.4% Weak Weak Year-over-year change in net income	—	—	—
FCF Growth YoY (%)	85.4% Excellent Excellent Year-over-year change in free cash flow	—	—	-157.1% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Jun 7, 2007 10-K ↗
FCF / Net Income (x)	0.83x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.33x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.20x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.13x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Jun 7, 2007 10-K ↗
Return on Invested Capital (%)	-40.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-72.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-80.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-42.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-33.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-45.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-241.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-87.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-68.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-121.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-94.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-60.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-132.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1060.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	108.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	868.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-45.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-83.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-76.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-49.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-38.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-51.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-198.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-100.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-79.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-141.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-102.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-69.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-124.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-607.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-794.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-1048.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-50.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-437%)	-93.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-721%)	-110.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-837%)	-53.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-455%)	-42.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-381%)	-57.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-484%)	—	-110.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-835%)	-85.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-672%)	-153.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1121%)	-119.4% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-896%)	-76.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-610%)	-167.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1214%)	—	141.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+843%)	—	41.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+174%)	37.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+147%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Jun 7, 2007 10-K ↗
Debt to Equity (x)	—	0.06x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-90%)	0.10x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-83%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	-1412.39x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-110.78x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1345.23x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	-4078.80x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-36.89x Weak Weak Operating income divided by interest expense Optimal: > 5x	-53.90x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—
Net Debt (USD)	$-207.64M	$-90.13M	$-13.95M	$-120.23M	$-178.66M	$-77.07M	$-11.25M	$-25.03M	$-25.50M	$-18.94M	$-19.18M	$-38.18M	—	—	—	—	—	—	—	—
Debt / EBITDA (x)	—	-0.06x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.10x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Jun 7, 2007 10-K ↗
Revenue per Share (USD)	$1.54	$13.71	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-14.57	$-176.60	$-14.72K	$-20.01	$-8.10	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-12.13	$-82.90	—	$-25.03	$-9.74	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$19.17	$31.82	—	$16.75	$13.99	$0.43	$1.10	$1.55	$31.32	$64.71	$21.38	$33.40	$11.18	$0.22	$-0.91	$-0.10	—	—	—	—
Tangible Book Value per Share (USD)	$19.16	$31.79	—	$16.74	$13.99	$0.42	$1.09	$1.54	$31.17	$64.40	$21.32	$33.40	$11.18	$0.22	$-0.91	$-0.10	—	—	—	—
Basic Weighted Avg Shares (shares)	8.51M	736,339	7,925	5.84M	11.39M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Jun 7, 2007 10-K ↗
Working Capital (USD)	$198.04M	$100.69M	$28.88M	$112.60M	$167.33M	$78.17M	$8.81M	$23.40M	$24.32M	$25.02M	$39.71M	$35.65M	$6.42M	$871.26K	$-781.72K	$-251.61K	—	—	—	—
LT Debt (USD)	—	$8.65M	$11.00M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$245.15M	$139.56M	$105.53M	$207.18M	$218.72M	$87.65M	$9.42M	$23.66M	$24.62M	$25.36M	$40.26M	$36.09M	$6.51M	$958.71K	$-2.45M	$-175.45K	$-537.00K	$-545.00K	$-415.00K	$0.00

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Jun 7, 2007 10-K ↗
Sales/Revenue/Turnover (USD)	$13.11M	$10.09M	$7.77M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$1.93M	$3.42M	$4.29M	$1.25M	$50.00K	$27.00K	$26.00K	$54.00K	$70.00K	$206.00K	$161.00K	$36.00K	$17.00K	$31.64K	$9.30K	$3.85K	—	—	—	—
Net Income, GAAP (USD)	$-124.02M	$-130.04M	$-116.66M	$-110.22M	$-92.29M	$-50.46M	$-28.62M	$-26.09M	$-21.12M	$-38.84M	$-48.05M	$-27.62M	$-10.88M	$-15.84M	$-3.47M	$-1.96M	$-221.00K	$-202.00K	—	—
Operating Cash Flow (USD)	$-99.84M	$-60.92M	$-102.00M	$-98.05M	$-75.56M	$-48.57M	$-26.68M	$-23.97M	$-19.13M	$-37.31M	—	—	—	$-10.20M	$-2.64M	$-1.23M	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 68 quarters

Tonix Pharmaceuticals Holding Corp.

Analytical Summary

20-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TNXP with peers